Quantitative analysis of tumor-specific BCL2 expression in DLBCL: refinement of prognostic relevance of BCL2

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2045-2322

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Quantitative analysis of tumor-specific BCL2 expression in DLBCL: refinement of prognostic relevance of BCL2 ; volume:10 ; number:1 ; day:30 ; month:6 ; year:2020 ; pages:1-11 ; date:12.2020
Scientific reports ; 10, Heft 1 (30.6.2020), 1-11, 12.2020

Creator: Roh, Jin
Cho, Hyungwoo
Yoon, Dok Hyun
Hong, Jung Yong
Lee, A-Neum
Eom, Hyeon Seok
Lee, Hyewon
Park, Weon Seo
Han, Jae Ho
Jeong, Seong Hyun
Park, Joon Seong
Pak, Hyo-Kyung
Kim, So-Woon
Kim, Sang-Yeob
Suh, Cheolwon
Huh, Jooryung
Park, Chan-Sik

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41598-020-67738-4

URN: urn:nbn:de:101:1-2020082100394117965597

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:52 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Roh, Jin
Cho, Hyungwoo
Yoon, Dok Hyun
Hong, Jung Yong
Lee, A-Neum
Eom, Hyeon Seok
Lee, Hyewon
Park, Weon Seo
Han, Jae Ho
Jeong, Seong Hyun
Park, Joon Seong
Pak, Hyo-Kyung
Kim, So-Woon
Kim, Sang-Yeob
Suh, Cheolwon
Huh, Jooryung
Park, Chan-Sik
SpringerLink (Online service)

Other Objects (12)

GNA13 regulates BCL2 expression and the sensitivity of GCB-DLBCL cells to BCL2 inhibitors in a palmitoylation-dependent manner

Bcl2 inhibition of mitochondrial DNA repair

Targeted inhibition of DHODH is synergistic with BCL2 blockade in HGBCL with concurrent MYC and BCL2 rearrangement

CD23-positive, BCL2-Rearrangement-negative Keimzentrumslymphome

BCL2 genotypes and prostate cancer survival

Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients

A BCL2 promoter polymorphism rs2279115 is not associated with BCL2 protein expression or patient survival in breast cancer patients

Survival of midbrain dopamine neurons depends on the Bcl2 factor Mcl1

Phenotyping of cancer-associated somatic mutations in the BCL2 transmembrane domain

Computational study on novel natural inhibitors targeting BCL2

Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes

Primary follicular lymphoma of the epididymis positive for t(14;18)(q32;q21)/IGH- BCL2 and negative for BCL2 protein expression: a case report

GNA13 regulates BCL2 expression and the sensitivity of GCB-DLBCL cells to BCL2 inhibitors in a palmitoylation-dependent manner

Bcl2 inhibition of mitochondrial DNA repair

Targeted inhibition of DHODH is synergistic with BCL2 blockade in HGBCL with concurrent MYC and BCL2 rearrangement

CD23-positive, BCL2-Rearrangement-negative Keimzentrumslymphome

BCL2 genotypes and prostate cancer survival

Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients

A BCL2 promoter polymorphism rs2279115 is not associated with BCL2 protein expression or patient survival in breast cancer patients

Survival of midbrain dopamine neurons depends on the Bcl2 factor Mcl1

Phenotyping of cancer-associated somatic mutations in the BCL2 transmembrane domain

Computational study on novel natural inhibitors targeting BCL2

Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes

Primary follicular lymphoma of the epididymis positive for t(14;18)(q32;q21)/IGH- BCL2 and negative for BCL2 protein expression: a case report

GNA13 regulates BCL2 expression and the sensitivity of GCB-DLBCL cells to BCL2 inhibitors in a palmitoylation-dependent manner

Bcl2 inhibition of mitochondrial DNA repair

Targeted inhibition of DHODH is synergistic with BCL2 blockade in HGBCL with concurrent MYC and BCL2 rearrangement

CD23-positive, BCL2-Rearrangement-negative Keimzentrumslymphome

BCL2 genotypes and prostate cancer survival

Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients

A BCL2 promoter polymorphism rs2279115 is not associated with BCL2 protein expression or patient survival in breast cancer patients

Survival of midbrain dopamine neurons depends on the Bcl2 factor Mcl1

Phenotyping of cancer-associated somatic mutations in the BCL2 transmembrane domain

Computational study on novel natural inhibitors targeting BCL2

Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes

Primary follicular lymphoma of the epididymis positive for t(14;18)(q32;q21)/IGH- BCL2 and negative for BCL2 protein expression: a case report

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Quantitative analysis of tumor-specific BCL2 expression in DLBCL: refinement of prognostic relevance of BCL2

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

GNA13 regulates BCL2 expression and the sensitivity of GCB-DLBCL cells to BCL2 inhibitors in a palmitoylation-dependent manner

Bcl2 inhibition of mitochondrial DNA repair

Targeted inhibition of DHODH is synergistic with BCL2 blockade in HGBCL with concurrent MYC and BCL2 rearrangement

CD23-positive, BCL2-Rearrangement-negative Keimzentrumslymphome

BCL2 genotypes and prostate cancer survival

Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients

A BCL2 promoter polymorphism rs2279115 is not associated with BCL2 protein expression or patient survival in breast cancer patients

Survival of midbrain dopamine neurons depends on the Bcl2 factor Mcl1

Phenotyping of cancer-associated somatic mutations in the BCL2 transmembrane domain

Computational study on novel natural inhibitors targeting BCL2

Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes

Primary follicular lymphoma of the epididymis positive for t(14;18)(q32;q21)/IGH- BCL2 and negative for BCL2 protein expression: a case report

GNA13 regulates BCL2 expression and the sensitivity of GCB-DLBCL cells to BCL2 inhibitors in a palmitoylation-dependent manner

Bcl2 inhibition of mitochondrial DNA repair

Targeted inhibition of DHODH is synergistic with BCL2 blockade in HGBCL with concurrent MYC and BCL2 rearrangement

CD23-positive, BCL2-Rearrangement-negative Keimzentrumslymphome

BCL2 genotypes and prostate cancer survival

Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients

A BCL2 promoter polymorphism rs2279115 is not associated with BCL2 protein expression or patient survival in breast cancer patients

Survival of midbrain dopamine neurons depends on the Bcl2 factor Mcl1

Phenotyping of cancer-associated somatic mutations in the BCL2 transmembrane domain

Computational study on novel natural inhibitors targeting BCL2

Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes

Primary follicular lymphoma of the epididymis positive for t(14;18)(q32;q21)/IGH- BCL2 and negative for BCL2 protein expression: a case report

GNA13 regulates BCL2 expression and the sensitivity of GCB-DLBCL cells to BCL2 inhibitors in a palmitoylation-dependent manner

Bcl2 inhibition of mitochondrial DNA repair

Targeted inhibition of DHODH is synergistic with BCL2 blockade in HGBCL with concurrent MYC and BCL2 rearrangement

CD23-positive, BCL2-Rearrangement-negative Keimzentrumslymphome

BCL2 genotypes and prostate cancer survival

Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients

A BCL2 promoter polymorphism rs2279115 is not associated with BCL2 protein expression or patient survival in breast cancer patients

Survival of midbrain dopamine neurons depends on the Bcl2 factor Mcl1

Phenotyping of cancer-associated somatic mutations in the BCL2 transmembrane domain

Computational study on novel natural inhibitors targeting BCL2

Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes

Primary follicular lymphoma of the epididymis positive for t(14;18)(q32;q21)/IGH- BCL2 and negative for BCL2 protein expression: a case report

Related objects

Reset password